These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27585952)

  • 1. Chronic myelomonocytic leukemia patients with RAS pathway mutations show high in vitro myeloid colony formation in the absence of exogenous growth factors.
    Geissler K; Jäger E; Barna A; Alendar T; Ljubuncic E; Sliwa T; Valent P
    Leukemia; 2016 Nov; 30(11):2280-2281. PubMed ID: 27585952
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular Basis and Clinical Application of Growth-Factor-Independent In Vitro Myeloid Colony Formation in Chronic Myelomonocytic Leukemia.
    Geissler K; Jäger E; Barna A; Gurbisz M; Graf T; Graf E; Nösslinger T; Pfeilstöcker M; Machherndl-Spandl S; Stauder R; Zebisch A; Sill H; Öhler L; Kusec R; Hörmann G; Valent P
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
    Ricci C; Fermo E; Corti S; Molteni M; Faricciotti A; Cortelezzi A; Lambertenghi Deliliers G; Beran M; Onida F
    Clin Cancer Res; 2010 Apr; 16(8):2246-56. PubMed ID: 20371679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 Patients.
    Geissler K; Jäger E; Barna A; Gurbisz M; Graf T; Graf E; Nösslinger T; Pfeilstöcker M; Tüchler H; Sliwa T; Keil F; Geissler C; Heibl S; Thaler J; Machherndl-Spandl S; Zach O; Weltermann A; Bettelheim P; Stauder R; Zebisch A; Sill H; Schwarzinger I; Schneeweiss B; Öhler L; Ulsperger E; Kusec R; Germing U; Sperr WR; Knöbl P; Jäger U; Hörmann G; Valent P
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic myelomonocytic leukemia: Tel-a-kinase what Ets all about.
    Sawyers CL; Denny CT
    Cell; 1994 Apr; 77(2):171-3. PubMed ID: 8168126
    [No Abstract]   [Full Text] [Related]  

  • 6. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
    Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC
    Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juvenile myelomonocytic leukemia.
    Emanuel PD
    Curr Hematol Rep; 2004 May; 3(3):203-9. PubMed ID: 15087069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation.
    Kuo MC; Liang DC; Huang CF; Shih YS; Wu JH; Lin TL; Shih LY
    Leukemia; 2009 Aug; 23(8):1426-31. PubMed ID: 19282830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-phenotype correlation in cases of juvenile myelomonocytic leukemia with clonal RAS mutations.
    Flotho C; Kratz CP; Bergsträsser E; Hasle H; Starý J; Trebo M; van den Heuvel-Eibrink MM; Wójcik D; Zecca M; Locatelli F; Niemeyer CM;
    Blood; 2008 Jan; 111(2):966-7; author reply 967-8. PubMed ID: 18182584
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia.
    Loghavi S; Curry JL; Garcia-Manero G; Patel KP; Xu J; Khoury JD; Torres-Cabala CA; Nagarajan P; Aung PP; Gibson BR; Goodwin BP; Kelly BC; Korivi BR; Medeiros LJ; Prieto VG; Kantarjian HM; Bueso-Ramos CE; Tetzlaff MT
    J Cutan Pathol; 2017 Dec; 44(12):1075-1079. PubMed ID: 28885734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic myelomonocytic leukemia: molecularly contaminated, but not defined.
    Patnaik MM; Tefferi A
    Leuk Lymphoma; 2016 Aug; 57(8):1751-2. PubMed ID: 27063331
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.
    Ouyang Y; Qiao C; Chen Y; Zhang SJ
    Oncotarget; 2017 Mar; 8(13):20834-20841. PubMed ID: 28209919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low frequency of ras oncogene mutations in Philadelphia-positive acute leukemia and report of a novel mutation H61 Leu in a single case.
    Urbano-Ispizua A; Gill R; Matutes E; Levi S; Wiedemann LM; Catovsky D; Marshall CJ
    Leukemia; 1992 Apr; 6(4):342-6. PubMed ID: 1588796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KRAS mutations, autoimmunity and female sex in chronic myelomonocytic leukemia.
    Osman AEG; Rets A; Patel AB
    Leuk Res; 2024 Mar; 138():107466. PubMed ID: 38430640
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic myelomonocytic leukemia: myeloproliferative variant.
    Onida F; Beran M
    Curr Hematol Rep; 2004 May; 3(3):218-26. PubMed ID: 15087071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias.
    Damm F; Itzykson R; Kosmider O; Droin N; Renneville A; Chesnais V; Gelsi-Boyer V; de Botton S; Vey N; Preudhomme C; Clavert A; Delabesse E; Park S; Birnbaum D; Fontenay M; Bernard OA; Solary E
    Leukemia; 2013 Jun; 27(6):1401-3. PubMed ID: 23443343
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of immunohistochemical results of the ras oncogene product p21 in myelodysplastic syndromes.
    Kalmantis T; Kalmanti M; Vassilaki M; Spandidos DA
    Anticancer Res; 1993; 13(4):1103-6. PubMed ID: 8352532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 Protein expression in chronic myelomonocytic leukemia-1 correlates with progression to leukemia and a poor prognosis.
    Hattori N; Fukuchi K; Nakamaki T; Homma M; Ariizumi H; Nakashima H; Maeda T; Saito B; Yamochi-Onizuka T; Yanagisawa K; Matsuda I; Ota H; Tomoyasu S
    Acta Haematol; 2011; 125(4):242-6. PubMed ID: 21335959
    [No Abstract]   [Full Text] [Related]  

  • 19. RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation.
    Ballerini P; Struski S; Cresson C; Prade N; Toujani S; Deswarte C; Dobbelstein S; Petit A; Lapillonne H; Gautier EF; Demur C; Lippert E; Pages P; Mansat-De Mas V; Donadieu J; Huguet F; Dastugue N; Broccardo C; Perot C; Delabesse E
    Leukemia; 2012 Nov; 26(11):2384-9. PubMed ID: 22513837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
    Boultwood J; Perry J; Pellagatti A; Fernandez-Mercado M; Fernandez-Santamaria C; Calasanz MJ; Larrayoz MJ; Garcia-Delgado M; Giagounidis A; Malcovati L; Della Porta MG; Jädersten M; Killick S; Hellström-Lindberg E; Cazzola M; Wainscoat JS
    Leukemia; 2010 May; 24(5):1062-5. PubMed ID: 20182461
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.